246,160 Shares in Encompass Health Corp (EHC) Acquired by Robeco Institutional Asset Management B.V.

Share on StockTwits

Robeco Institutional Asset Management B.V. bought a new position in shares of Encompass Health Corp (AMEX:EHC) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 246,160 shares of the company’s stock, valued at approximately $19,203,000. Robeco Institutional Asset Management B.V. owned approximately 0.25% of Encompass Health as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of EHC. UBS Group AG bought a new position in shares of Encompass Health in the first quarter valued at $1,424,000. Ladenburg Thalmann Financial Services Inc. bought a new position in shares of Encompass Health in the first quarter valued at $336,000. LPL Financial LLC bought a new position in shares of Encompass Health in the first quarter valued at $804,000. Legal & General Group Plc bought a new position in shares of Encompass Health in the first quarter valued at $7,198,000. Finally, WINTON GROUP Ltd bought a new position in shares of Encompass Health in the first quarter valued at $339,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Cheryl B. Levy sold 28,955 shares of the firm’s stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $78.00, for a total transaction of $2,258,490.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Andrew L. Price sold 9,457 shares of the firm’s stock in a transaction dated Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total transaction of $756,938.28. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

EHC opened at $57.67 on Wednesday. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. Encompass Health Corp has a fifty-two week low of $40.86 and a fifty-two week high of $59.29.

Encompass Health (AMEX:EHC) last released its quarterly earnings results on Monday, October 29th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.12. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. The firm’s revenue was up 8.8% compared to the same quarter last year. On average, analysts expect that Encompass Health Corp will post 2.72 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Investors of record on Wednesday, January 2nd will be issued a dividend of $0.27 per share. The ex-dividend date is Monday, December 31st. This represents a $1.08 dividend on an annualized basis and a yield of 1.87%.

A number of research analysts have weighed in on EHC shares. Zacks Investment Research lowered shares of Encompass Health from a “hold” rating to a “sell” rating in a research note on Tuesday, October 16th. Credit Suisse Group raised their price target on shares of Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. SunTrust Banks reissued a “buy” rating and set a $82.00 price target on shares of Encompass Health in a research report on Friday, July 20th. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Finally, Mizuho reissued a “buy” rating and set a $82.00 price target on shares of Encompass Health in a research report on Thursday, July 26th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. Encompass Health currently has an average rating of “Buy” and an average price target of $71.10.

Encompass Health Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: Hedge Funds

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply